Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins

Ten epidemiologically unrelated Staphylococcus aureus isolates with borderline levels of susceptibility to antistaphylococcal penicillinase-resistant penicillins (PRPs) were investigated together with appropriate S. aureus control strains. By a nitrocefin microplate assay, all borderline PRP-susceptible test strains were found to produce comparable amounts of beta-lactamase. Hydrolytic activity against another chromogenic substrate (PADAC) and against the PRPs was also demonstrated in membrane preparations from induced cells of 9 of the 10 borderline test strains. When bacterial membranes were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, two methicillin-inducible bands of about 32 and 31 kDa were detected, after Coomassie blue staining, in the membrane protein patterns of the same nine borderline test strains. By gel renaturation and zymographic detection of beta-lactamase activity, both methicillin-inducible membrane proteins were detected with nitrocefin as a substrate, whereas only one band (presumably the smaller protein) was detected with PADAC. With the remaining borderline test strain (a40), only the larger band was detected in the renatured gels with nitrocefin as a substrate. Plasmid DNA analysis revealed that the borderline susceptible test strains, again with the exception of a40, shared a 17.2-kb plasmid yielding four HindIII fragments of 7.0, 5.3, 3.5, and 1.4 kb. In Western blot (immunoblot) experiments using rabbit antiserum to penicillin-binding protein (PBP) 2a, test strain a40, which did not share a number of features characteristically associated with the other borderline test strains, was eventually shown to produce PBP 2a. Five other S. aureus strains, belonging to phage group 94/96, were found to display the borderline phenotype, including such distinguishing features as the membrane-associated PRP- and PADAC-hydrolyzing activity, the two methicillin-inducible membrane proteins, and the 17.2-kb plasmid. These results suggest that borderline susceptible S. aureus strains share more common features than reduced susceptibility to PRPs.

[1]  L. Mcdougal,et al.  The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins , 1986, Journal of clinical microbiology.

[2]  T. Kobayashi,et al.  A second regulatory gene, blaR1, encoding a potential penicillin-binding protein required for induction of beta-lactamase in Bacillus licheniformis , 1987, Journal of bacteriology.

[3]  M. P. Montanari,et al.  Evidence for a methicillin-hydrolysing beta-lactamase in Staphylococcus aureus strains with borderline susceptibility to this drug. , 1992, FEMS microbiology letters.

[4]  J. Maclowry,et al.  Phage pattern-specific oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus in U.S. hospitals: epidemiological significance , 1992, Journal of clinical microbiology.

[5]  R. Novick,et al.  Penicillinase plasmids of Staphylococcus aureus: structural and evolutionary relationships. , 1980, Plasmid.

[6]  V. Rosdahl,et al.  Correlation of penicillinase production with phage type and susceptibility to antibiotics and heavy metals in Staphylococcus aureus. , 1983, Journal of medical microbiology.

[7]  E. Asheshov,et al.  Properties of strains of Staphylococcus aureus in the 94, 96 complex. , 1977, Journal of medical microbiology.

[8]  L. Mcdougal,et al.  Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci , 1983, Journal of clinical microbiology.

[9]  K. Dyke,et al.  Tn552, a novel transposable element from Staphylococcus aureus , 1990, Molecular microbiology.

[10]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[11]  M. P. Montanari,et al.  Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins , 1990, Antimicrobial Agents and Chemotherapy.

[12]  P. Varaldo The 'borderline methicillin-susceptible' Staphylococcus aureus. , 1993, The Journal of antimicrobial chemotherapy.

[13]  M. P. Montanari,et al.  Cloning and expression of the penicillinase from a borderline methicillin-susceptible Staphylococcus aureus strain in Escherichia coli. , 1994, FEMS microbiology letters.

[14]  A. Tomasz,et al.  New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity , 1989, Antimicrobial Agents and Chemotherapy.

[15]  J. Ghuysen,et al.  Identification of BlaR, the signal transducer for beta-lactamase production in Bacillus licheniformis, as a penicillin-binding protein with strong homology to the OXA-2 beta-lactamase (class D) of Salmonella typhimurium , 1990, Journal of bacteriology.

[16]  T. Kocagoz,et al.  Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance , 1995, Antimicrobial agents and chemotherapy.

[17]  D. Kernodle,et al.  Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections. , 1990, The Journal of infectious diseases.

[18]  R. Skurray,et al.  Antimicrobial resistance of Staphylococcus aureus: genetic basis. , 1987, Microbiological reviews.

[19]  G. Archer,et al.  Low-level methicillin resistance in strains of Staphylococcus aureus , 1989, Antimicrobial Agents and Chemotherapy.

[20]  S. Crawford,et al.  Pyridinium-2-azo-p-dimethylaniline chromophore, a new chromogenic cephalosporin for rapid beta-lactamase testing , 1982, Antimicrobial Agents and Chemotherapy.

[21]  A. Tomasz,et al.  Beta-lactam-specific resistant mutants of Staphylococcus aureus , 1986, Antimicrobial Agents and Chemotherapy.

[22]  B. Berger-Bächi,et al.  Natural methicillin resistance in comparison with that selected by in-vitro drug exposure in Staphylococcus aureus. , 1989, The Journal of antimicrobial chemotherapy.

[23]  J. Gerberding,et al.  Comparison of conventional susceptibility tests with direct detection of penicillin-binding protein 2a in borderline oxacillin-resistant strains of Staphylococcus aureus , 1991, Antimicrobial Agents and Chemotherapy.

[24]  D. Kernodle,et al.  Borderline susceptibility to antistaphylococcal penicillins is not conferred exclusively by the hyperproduction of beta-lactamase , 1991, Antimicrobial Agents and Chemotherapy.

[25]  J. Washington,et al.  Role of beta-lactamase and different testing conditions in oxacillin-borderline-susceptible staphylococci , 1988, Antimicrobial Agents and Chemotherapy.

[26]  C. Hackbarth,et al.  blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus , 1993, Antimicrobial Agents and Chemotherapy.

[27]  O. Massidda,et al.  The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo-beta-lactamases , 1991, Journal of bacteriology.

[28]  L. Mcdougal,et al.  New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci , 1984, Journal of clinical microbiology.

[29]  A. Tomasz,et al.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus , 1984, Journal of bacteriology.